Phacilitate Leaders World 



The world's largest advanced therapies partnering event

Welcome to Phacilitate Leaders World 2020! Taking place January 21 - 24, 2020 in Miami, this event will bring together the entire ecosystem of the advanced therapies industry from all corners of the globe.

At Phacilitate, we believe that through strong partnerships and collaboration, anything can be achieved. This award-winning event is the biggest and most influential global meeting for advanced therapies. Here you will meet more decision makers in four days than you can in four months.

Take a glance Behind the Scenes of Phacilitate Leaders World 2019



why attend phacilitate leaders europewhy attend phacilitate leaders europewhy attend phacilitate leaders europewhy attend phacilitate leaders europe

Phacilitate Leaders Europe roundtables
Phacilitate Leaders Europe speakers
Phacilitate Leaders Europe networking

Join the advanced therapies community 

Phacilitate LinkedIn Instagram Phacilitate Leaders Europe YouTube - Phacilitate Leaders Europe Twitter Phacilitate Leaders Europe


  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman